Creatine or Vitamin D Supplementation in Persons With Spinal Cord Injury Undergoing Resistance Training
NCT ID: NCT02099357
Last Updated: 2015-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2014-09-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Vitamin D Supplementation in Muscle Strength and Balance Training
NCT03367585
Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females
NCT05489666
Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period
NCT02092701
Effects of Vitamin D Supplementation on Strength, Bone Density, and Injury Risk in Collegiate Athletes
NCT03151174
Vitamin D and Resistance Exercise Training; Effects on Musculoskeletal Health in Frail Older Men and Women
NCT02467153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Daily supplementation with 3g of dextrose during eight weeks and placebo ampoules each two weeks.
Placebo
Creatine
Daily supplementation with 3g of monohydrate creatine during eight weeks. Placebo ampoules each two weeks.
Creatine
Daily supplementation with 3g of monohydrate creatine during 8 weeks
Vitamin D
Daily supplementation with 3g of dextrose during eight weeks. Vitamin D supplementation, 25000 IU each two weeks.
Vitamin D
Vitamin D supplementation with 25000 IU each two weeks during eight weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Creatine
Daily supplementation with 3g of monohydrate creatine during 8 weeks
Placebo
Vitamin D
Vitamin D supplementation with 25000 IU each two weeks during eight weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum time since injury: 3 months
Exclusion Criteria
* Creatine or vitamin D supplementation in the previous 6 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade do Porto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samuel Amorim
Bsc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vitor H Teixeira, PhD
Role: STUDY_DIRECTOR
Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto
Rui Corredeira, PhD
Role: STUDY_CHAIR
Faculdade de Desporto, Universidade do Porto
Samuel Amorim, Bsc
Role: PRINCIPAL_INVESTIGATOR
Faculdade de Desporto, Universidade do Porto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais
Cantanhede, Coimbra District, Portugal
Centro de Reabilitação do Norte
Vila Nova de Gaia, Porto District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FADEUPAFA20132015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.